Recombinant Human DEFB116 protein (denatured) (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human DEFB116 protein (denatured) (His tag N-Terminus) is a Human Full Length protein, in the 24 to 102 aa range, expressed in Escherichia coli, with >80%, suitable for SDS-PAGE.
View Alternative Names
DEFB16, DEFB116, Beta-defensin 116, Beta-defensin 16, DEFB-16
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human DEFB116 protein (denatured) (His tag N-Terminus) (AB171484)
15% SDS-PAGE analysis of ab171484 (3µg).
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DEFB116 acts as part of the body's first line of defense by contributing to antimicrobial and anti-inflammatory activity. It does not form part of a larger protein complex functioning independently to disrupt microbial membranes and neutralize pathogens. DEFB116 also plays a role in modulating the immune response by recruiting and activating immune cells like macrophages and dendritic cells.
Pathways
The action of DEFB116 spans the innate immune signaling and inflammatory response pathways. It interacts with components of the Toll-like receptor (TLR) and NF-kB signaling pathways essential for detecting and responding to microbial infections. DEFB116 shares relationships with other beta-defensins and cytokines like interleukin-1β which mediates inflammation and immune responses.
Specifications
Form
Liquid
General info
Function
Has antibacterial activity.
Sequence similarities
Belongs to the beta-defensin family.
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com